Should I buy Strategy (MSTR) stock or is it too late?
⭐ The most reliable of them, either direction: Canaccord Genuity — 61% of its targets hit on this sector (33 calls tested). It aims for $179 (+18 %), call made on September 9, 2026, maturing on September 9, 2027 (35 d ago).
Firm-by-firm track record on Strategy
| Firm | % right | Gain vs sector | Calls | Aims for |
|---|---|---|---|---|
| Canaccord Genuity | 67 % | +144.4 % | 18 | $179 +18% |
| BTIG | 43 % | +74.6 % | 7 | $250 +64% |
| TD Cowen | 67 % | +58.9 % | 9 | $260 +71% |
| Bernstein | 60 % | +52.0 % | 5 | $350 +130% |
| Benchmark | 55 % | +40.9 % | 11 | $435 +186% |
| Barclays | 57 % | +28.6 % | 7 | $175 +15% |
| Citigroup | 60 % | -5.6 % | 5 | $240 +58% |
| Cantor Fitzgerald | 20 % | -24.7 % | 5 | $186 +22% |
✅ Reasons to believe
- 100% of analysts rate it a buy (Buy consensus, 11 ratings) — a sign of market conviction.
- Median price target $215, i.e. +41% from the current price ($152).
- The most reliable firm on MSTR, Canaccord Genuity (67% hit rate, 18 scored calls), targets $179 (call made on September 8, 2026, maturing on September 8, 2027) (+18%) in its most recent call, and $474 (call made on November 3, 2025, maturing on November 3, 2026) (+211%) in the one coming due soonest.
⚠️ Reasons to hesitate
- A 12-month target is not a guaranteed path: the price can fall in the meantime.
- Volatile stock: sharp swings — including steep drops — are part of its profile.
- No dividend: your return depends only on price appreciation.
- A near-unanimous consensus leaves little room for positive surprise — a lot of optimism is already baked in.
The analyst consensus on MSTR
Median target $215 (+41%) · 11 ratings · Buy consensus
⚠️ Information, not investment advice. Past performance does not guarantee future results. Analyst targets on a ~12-month horizon.
Frequently asked questions
Should you invest in Strategy now?
We won't decide for you. The facts: 100% of analysts rate it a buy, median target $215 (+41%), and Canaccord Genuity (most reliable on MSTR, 67%) targets $179. Weigh that against valuation and volatility. This is not personalized advice.
Is it too late to invest in Strategy?
Not according to analysts: the median target ($215) is still +41% above the current price ($152) (most reliable on MSTR: Canaccord Genuity, 67%). The real question isn't "too late" but the price-to-value gap and risk. Not advice.
Is Strategy still worth investing in?
It depends on the gap between the price ($152) and its estimated value: analysts target $215 on median (+41%), with 100% buys (most reliable on MSTR: Canaccord Genuity, 67%). Cross-check with their real reliability on MSTR and the cautions above. Information, not advice.
What's the main risk in buying MSTR?
A 12-month target is not a guaranteed path: the price can fall in the meantime.
→ Go deeper: the full Strategy profile (consensus, analyst reliability, price target, performance).